Alpha Cognition (ACOG) Profit After Tax (2023 - 2026)
Alpha Cognition (ACOG) posted quarterly Profit After Tax of -$6.9 million for Q4 2025, down 18.0% year-over-year from -$8.4 million in Q4 2024, and down 420.18% quarter-over-quarter from -$1.3 million in Q3 2025.
Alpha Cognition (ACOG) Profit After Tax (2023 - 2026) Analysis & Trends
Alpha Cognition's Profit After Tax history runs 3 years deep, the most recent figure standing at -$6.9 million for Q4 2025.
- In Q4 2025, Profit After Tax fell 18.0% year-over-year to -$6.9 million; the TTM figure through Dec 2025 stood at -$20.7 million (down 39.77% YoY), while the FY2025 annual figure was -$20.7 million, down 39.77% from the prior year.
- Profit After Tax for Q4 2025 stood at -$6.9 million, down from -$1.3 million in the prior quarter.
- The five-year high for Profit After Tax was -$1.3 million in Q3 2025, with the low at -$10.5 million in Q2 2025.
- The 3-year median for Profit After Tax is -$3.3 million (2023), against an average of -$4.3 million.
- Peak annual rise in Profit After Tax reached 59.89% in 2025, while the deepest fall reached 395.81% in 2025.
- Alpha Cognition's Profit After Tax stood at -$5.7 million in 2023, then declined by 1.69% to -$5.8 million in 2024, then declined by 18.0% to -$6.9 million in 2025.
- Business Quant data shows ACOG's Profit After Tax at -$6.9 million in Q4 2025, -$1.3 million in Q3 2025, and -$10.5 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 472.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -16.62 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | Alpha Cognition | 219.48 Mn | 178.04 Mn | 5.70 Mn | -8.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.79 Mn |
| Dec 31, 2025 | -6.86 Mn |
| Sep 30, 2025 | -1.32 Mn |
| Jun 30, 2025 | -10.49 Mn |
| Mar 31, 2025 | -2.01 Mn |
| Dec 31, 2024 | -5.81 Mn |
| Sep 30, 2024 | -1.86 Mn |
| Jun 30, 2024 | -2.12 Mn |
| Mar 31, 2024 | -5.00 Mn |
| Dec 31, 2023 | -5.71 Mn |
| Sep 30, 2023 | -3.28 Mn |
| Jun 30, 2023 | -2.82 Mn |